Invasive Neurostimulation During Pregnancy for Treatment of Epilepsy and Tourette Syndrome
Pregnancy complications were consistent with previous reports of patients with neurologic disorders. Despite limitations in sample size and confounding factors related to medication use and neurologic diagnosis, our study suggests that implanted neuromodulation devices do not seem to pose a risk of neuromodulation-related teratogenicity. While these data are promising and may provide some reassurance for patient counseling regarding pregnancy, further studies with larger sample sizes are necessary.
Authors
- Linda M. Szymanski (ORCID: https://orcid.org/0000-0002-3167-4222)
- Elizabeth A. Coon (ORCID: https://orcid.org/0000-0003-1206-0222)
- William O. Tatum (ORCID: https://orcid.org/0000-0002-4536-3791)
- Lauren Jackson (ORCID: https://orcid.org/0000-0003-4167-9489)
- Jeffrey W. Britton (ORCID: https://orcid.org/0000-0002-0147-8159)
- Gregory A. Worrell (ORCID: https://orcid.org/0000-0003-2916-0553)
- Cornelia Drees
- Brian N. Lundstrom (ORCID: https://orcid.org/0000-0002-5310-5549)
- Kelsey M. Smith (ORCID: https://orcid.org/0000-0001-8659-3801)
- Aisha Abdulrazaq (ORCID: https://orcid.org/0009-0007-6051-4766)
- Anhmai Vu
Institutions
- University of Minnesota (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Neurology Clinical Practice
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1212/cpj.0000000000200498
- Citations
- 3
- Primary Topic
- Obsessive-Compulsive Spectrum Disorders
- Type
- article
- Field-Weighted Citation Impact
- 6.92